The U.S. may add new warning labels on alcohol. But the history of cigarette warning labels suggests it's not enough.

“Abrupt” reductions in antidepressant treatment “ranging from 20 percent to 50 percent” Increases in psychotropic drug ...

The TRAVERSE trial, a large-scale clinical study with over 5,000 patients, published in 2023, concluded that TRT does not increase the risk of adverse cardiovascular outcomes in men with hypogonadism.

But while nutrition experts have welcomed the FDA’s proposed policy change, the addition of warning labels to packaged goods hasn’t been shown to reduce the very real burden of chronic diseases.